✦ LIBER ✦

Is Late Luminal Loss an Accurate Predictor of the Clinical Effectiveness of Drug-Eluting Stents in the Coronary Arteries?

✍ Scribed by Pierfrancesco Agostoni; Marco Valgimigli; Antonio Abbate; John Cosgrave; Mara Pilati; Giuseppe G.L. Biondi-Zoccai

Book ID: 113442638
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 65 KB
Volume: 97
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2005.09.095

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Coronary late lumen loss of drug eluting

Coronary late lumen loss of drug eluting stents is associated with increased serum levels of the complement components C3a and C5a

✍ Walter S. Speidl; Katharina M. Katsaros; Stefan P. Kastl; Gerlinde Zorn; Kurt Hu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

Clinical value of drug-eluting stent ove

Clinical value of drug-eluting stent over bare-metal stents in large coronary arteries in the patients with ST-segment elevation myocardial infarction

✍ Abe, D.; Sato, A.; Maruta, S.; Misaki, M.; Hoshi, T.; Takeyasu, N.; Aonuma, K. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 418 KB

A randomized, prospective, intercontinen

A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial

✍ Saito, S.; Valdes-Chavarri, M.; Richardt, G.; Moreno, R.; Iniguez Romo, A.; Barb 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 553 KB

Improved Late Clinical Safety With Zotar

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial

✍ Martin B. Leon; Eugenia Nikolsky; Donald E. Cutlip; Laura Mauri; Henry Liberman; 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 557 KB

AS-148: Angiographic and Clinical Outcom

AS-148: Angiographic and Clinical Outcomes of Drug-Eluting Stents (Cypher and Taxus) Deployed in the Aorto-Ostium of the Right Coronary Artery (PCA)

✍ Yasunari Sakamoto; Toshiya Muramatsu; Reiko Tsukahara; Yoshiaki Ito; Tsuyoshi Sa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 31 KB